[1]
2023. An N-of-1 Trial in a Progressive Rare Disease: A Case Report on Design, Consent and Interpretation. Translational Medicine & Therapeutics Journal. 2, 1 (May 2023), 37–45. DOI:https://doi.org/10.5281/zenodo.22649050.